Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
2.

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: a systematic review.

Rys P, Pankiewicz O, Łach K, Kwaskowski A, Skrzekowska-Baran I, Malecki MT.

Diabetes Metab. 2011 Jun;37(3):190-200. doi: 10.1016/j.diabet.2010.12.003. Epub 2011 Feb 17. Review.

PMID:
21333580
3.

Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.

Bradley C, Gilbride CJ.

Diabetes Obes Metab. 2008 Jul;10 Suppl 2:50-65. doi: 10.1111/j.1463-1326.2008.00871.x. Review.

PMID:
18577157
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
5.

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.

Reynolds NA, Wagstaff AJ.

Drugs. 2004;64(17):1957-74. Review.

PMID:
15329046
6.

Insulin therapy and quality of life. A review.

Pouwer F, Hermanns N.

Diabetes Metab Res Rev. 2009 Sep;25 Suppl 1:S4-S10. doi: 10.1002/dmrr.981. Review.

PMID:
19662621
7.
8.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
9.

Biphasic insulin aspart 30: literature review of adverse events associated with treatment.

Davidson J, Vexiau P, Cucinotta D, Vaz J, Kawamori R.

Clin Ther. 2005;27 Suppl B:S75-88. Review.

PMID:
16519039
10.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

11.

Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.

Plank J, Siebenhofer A, Berghold A, Jeitler K, Horvath K, Mrak P, Pieber TR.

Arch Intern Med. 2005 Jun 27;165(12):1337-44. Review.

PMID:
15983281
12.

Insulin aspart: promising early results borne out in clinical practice.

Heller S, Kurtzhals P, Verge D, Lindholm A.

Expert Opin Pharmacother. 2002 Feb;3(2):183-95. Review.

PMID:
11829732
13.

Quality of life after pancreas transplantation: a review.

Gross CR, Limwattananon C, Matthees BJ.

Clin Transplant. 1998 Aug;12(4):351-61. Review.

PMID:
9686331
14.

[My approach to the management of a type I diabetic treated with short-acting insulin analogue].

Colombel A, Charbonnel B.

Journ Annu Diabetol Hotel Dieu. 1999:165-77. Review. French. No abstract available.

PMID:
10732416
15.

Diversity in diabetes: the role of insulin aspart.

Heller S, McCance DR, Moghissi E, Nazeri A, Kordonouri O.

Diabetes Metab Res Rev. 2012 Jan;28(1):50-61. doi: 10.1002/dmrr.1240. Review.

PMID:
21695769
16.

[Research regarding proper use of insulin in diabetes patients].

Asakura T.

Yakugaku Zasshi. 2001 Sep;121(9):653-61. Review. Japanese.

17.

The effects of Panax ginseng on quality of life.

Coleman CI, Hebert JH, Reddy P.

J Clin Pharm Ther. 2003 Feb;28(1):5-15. Review.

PMID:
12605613
18.

Human versus animal insulin in people with diabetes mellitus. A systematic review.

Richter B, Neises G, Bergerhoff K.

Endocrinol Metab Clin North Am. 2002 Sep;31(3):723-49. Review.

PMID:
12227129
19.

Patient perceptions of diabetes and diabetes therapy: assessing quality of life.

Bradley C, Speight J.

Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S64-9. Review.

PMID:
12324988
20.

Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms.

Rasmussen CH, Røge RM, Ma Z, Thomsen M, Thorisdottir RL, Chen JW, Mosekilde E, Colding-Jørgensen M.

Eur J Pharm Sci. 2014 Oct 1;62:65-75. doi: 10.1016/j.ejps.2014.05.010. Epub 2014 May 27. Review.

PMID:
24878388

Supplemental Content

Support Center